Target intelligence / Profile preview

SSU72 RNA polymerase II CTD phosphatase homolog pseudogene 3 (SSU72L3)

Target
SSU72L3
Molecular classification
Other
01

Overview

SSU72 RNA polymerase II CTD phosphatase homolog pseudogene 3 (abbreviated as SSU72L3) is classified as a **pseudogene** rather than a protein-coding gene. Unlike the canonical SSU72, which encodes a bona fide CTD phosphatase involved in transcriptional regulation, SSU72L3 does not produce a functional protein and therefore does not have enzymatic activity, established molecular function, or therapeutic target status. No role in human disease or drug interaction has been documented. The canonical functional gene, SSU72, is an essential phosphatase with critical roles in the transcription cycle and pre-mRNA processing, but SSU72L3 is not functionally equivalent to SSU72 and is not considered a valid therapeutic target[5]. **Key points:** - SSU72L3 is a pseudogene, not a functional target. - The functional enzyme is encoded by the SSU72 gene, not SSU72L3. - No known therapeutic targeting, mechanism, disease link, or interaction profile is associated with SSU72L3[5]. If your intent was to inquire about the canonical, functional human **SSU72 enzyme**, please clarify, as all known data indicate SSU72L3 is a pseudogene and not a therapeutic target[5].

Other names
SSU72 like 3SSU72L3RNA polymerase II subunit A C-terminal domain phosphatase SSU72 like protein 3CTD phosphatase SSU72L3SSU72P3SSU72 pseudogene 3

Beyond the preview

Go deeper on SSU72 RNA polymerase II CTD phosphatase homolog pseudogene 3 (SSU72L3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SSU72 RNA polymerase II CTD phosphatase homolog pseudogene 3 (SSU72L3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call